This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Nutrient Levels Alter Transplant Outcome

This study has been completed.
National Institutes of Health (NIH)
Information provided by:
University of Cincinnati Identifier:
First received: November 14, 2007
Last updated: November 16, 2007
Last verified: October 2007
The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.

Condition Intervention
Chronic Renal Disease Dietary Supplement: Arginine and canola oil Dietary Supplement: Coromega and Arginine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Role of Immunonutrient Levels in Preventing Complications After Renal Transplantation

Resource links provided by NLM:

Further study details as provided by University of Cincinnati:

Primary Outcome Measures:
  • Plasma and red blood cell lipid profiles [ Time Frame: Within 1 year ]
  • Plasma amino acid profiles [ Time Frame: within 1 year ]

Enrollment: 54
Study Start Date: September 1997
Study Completion Date: May 2005
Arms Assigned Interventions
Experimental: 1
Arginine and Canola oil supplemented group
Dietary Supplement: Arginine and canola oil
Canola oil 1 tablespoon BID Arginine 9.0grams BID
Other Name: Arginaid
Experimental: 2
Arginine and Coromega
Dietary Supplement: Coromega and Arginine
Arginine 9.0 grams BID Coromega dose based on weight
Other Name: Arginaide
No Intervention: 3


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Renal transplant recipient
  • Appropriate blood samples drawn and analyzed
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00560014

United States, District of Columbia
Washington Hospital
Washington, District of Columbia, United States, 20010
United States, North Carolina
Duke University School Of Medicine
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
University of Cincinnati
National Institutes of Health (NIH)
Principal Investigator: J. W. Alexander, M.D. UC Surgeons Center fo Surgical Weight Loss/ University of Cincinnati
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00560014     History of Changes
Other Study ID Numbers: LIPIDS
R03 AI142743
5U01AI040167 ( U.S. NIH Grant/Contract )
Study First Received: November 14, 2007
Last Updated: November 16, 2007

Additional relevant MeSH terms:
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases processed this record on August 17, 2017